Mann, J.M., Tarantola, D.J.M. & Netter, T.W. AIDS in the World (Harvard University Press, Cambridge, 1992).
Bird, K.D. The use of spermicide containing nonoxynol-9 in the prevention of HIV infection. AIDS 5, 791–796 (1991).
Steele, F. AIDS drugs lurch towards market. Nature Med. 1, 285–286 (1995).
Forthal, D.N., Landucci, G., Gorny, M.K., Zolla-Pazner, S. & Robinson, W.E., Jr., Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies. AIDS Res. Hum. Retrovir. 11, 1095–1099 (1995).
Miller, C.J., McGhee, J.R. & Gardner, M.B. Biology of disease: Mucosal immunity, HIV transmission, and AIDS. Lab. Invest. 68, 129–145 (1992).
Sattentau, Q.J. et al. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 2, 101–105 (1988).
Healey, D. et al. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp. Med. 172, 1233–1242 (1990).
Sattentau, Q.J. et al. Structural analysis of the human immunodeficiency virus-binding domain of CD4: Epitope mapping with site-directed mutants and anti-idiotypes. J. Exp. Med. 170, 1319–1334 (1989).
Muller, R. Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. in Methods in Enzymology. Immunochemical Techniques. Part E. Monoclonal Antibodies and General Immunoassay Methods (eds Langone, J.J. & Van Vunakis, H.) 589–601 (Academic Press, 1983).
Stoddard, B.L. & Koshland, D.E., Jr., Prediction of the structure of a receptor-protein complex using a binary docking method. Nature 358, 774–776 (1992).
Garrett, T.P.J., Wang, J., Yan, Y., Liu, J. & Harrison, S.C. Refinement and analysis of the structure of the first two domains of human CD4. J. Mol. Biol. 234, 763–778 (1993).
Sato, H., Orenstein, J., Dimitrov, D. & Martin, M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186, 712–724 (1992).
Kimpton, J. & Emerman, M. Detection of replication-competent and pseudo-typed human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Viral. 66, 2232–2239 (1992).
Allaway, G.P. et al. Expression and characterization of CD4-IgG2, a novel het-erotetramer that neutralizes primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses 11, 533–539 (1995).
Daar, E.S., Li, X.L., Moudgil, T. & Ho, D.D. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87, 6574–6578 (1990).
Morr, C.V. & Ha, E.Y.W. Whey protein concentrates and isolates: processing and functional properties. Crit. Rev. Food Sci. Nutr. 33, 431–476 (1993).
Gartner, S. & Popovic, M. Virus isolation and production. in Techniques in HIV Research (eds Aldovini, A. & Walker, B.D.) 53–70 (Stockton, New York, 1990).
Jiang, S., Lin, K., Strick, N. & Neurath, A.R. HIV-1 inhibition by a peptide. Nature 365, 113 (1993).
Neurath, A.R., Strick, N., Haberfleld, P. & Jiang, S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. II. Porphyrins reacting with the V3 loop of gp120. Antiviral Chem. Chemother. 3, 55–63 (1992).
Neurath, A.R., Strick, N. & Sproul, P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J. Exp. Med. 175, 461–469 (1992).
Kraulis, P.J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946–950 (1991).
Monaco, H.L. et al. Crystal structure of the trigonal form of bovine beta-lac-toglobulin and of its complex with retinol at 2.5 Å resolution. J. Mol. Biol. 197, 695–706 (1987).
Goodsell, D.S. & Olson, A.J. Automated docking of substrates to proteins by simulated annealing. Prot. Struct. Fund. Genet. 8, 195–202 (1990).